AR044113A1 - Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas - Google Patents
Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activasInfo
- Publication number
- AR044113A1 AR044113A1 ARP040101436A ARP040101436A AR044113A1 AR 044113 A1 AR044113 A1 AR 044113A1 AR P040101436 A ARP040101436 A AR P040101436A AR P040101436 A ARP040101436 A AR P040101436A AR 044113 A1 AR044113 A1 AR 044113A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogel
- pharmaceutical composition
- active substances
- transdermal administration
- carboxylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Composición farmacéutica en forma de hidrogel que comprende un diéster de ácido carboxílico, un alquilalcohol-C2-4, una sustancia activa, como por ejemplo un esteroide y una matriz de polímero. La presente se refiere también, al uso de un diéster de ácido carboxílico como intermediario de permeación transdérmica para una sustancia activa de una composición farmacéutica en forma de hidrogel, donde la composición comprende una matriz de polímero y un alquilalcohol-C2-4. Composición resistente a la transpiración en forma de hidrogel que comprende un polímero de acrilo en combinación con un derivado de celulosa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03008856 | 2003-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR044113A1 true AR044113A1 (es) | 2005-08-24 |
Family
ID=33395772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101436A AR044113A1 (es) | 2003-04-28 | 2004-04-28 | Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas |
Country Status (33)
| Country | Link |
|---|---|
| EP (2) | EP1875905B1 (es) |
| JP (2) | JP4829102B2 (es) |
| KR (1) | KR101093999B1 (es) |
| CN (1) | CN1780610B (es) |
| AR (1) | AR044113A1 (es) |
| AT (2) | ATE385786T1 (es) |
| AU (1) | AU2004233572B2 (es) |
| BR (1) | BRPI0409918A (es) |
| CA (1) | CA2523734C (es) |
| CL (1) | CL2004000884A1 (es) |
| CO (1) | CO5640075A2 (es) |
| CR (1) | CR8059A (es) |
| CY (1) | CY1108069T1 (es) |
| DE (2) | DE502004006196D1 (es) |
| DK (1) | DK1617827T3 (es) |
| EA (1) | EA008686B1 (es) |
| EC (1) | ECSP056186A (es) |
| ES (2) | ES2300763T3 (es) |
| HK (1) | HK1087633A1 (es) |
| HR (1) | HRP20080178T3 (es) |
| JO (1) | JO2492B1 (es) |
| MX (1) | MXPA05011541A (es) |
| NO (1) | NO20055601L (es) |
| NZ (2) | NZ543264A (es) |
| PE (1) | PE20050461A1 (es) |
| PL (1) | PL1617827T3 (es) |
| PT (1) | PT1617827E (es) |
| RS (1) | RS51307B (es) |
| SI (1) | SI1617827T1 (es) |
| TW (1) | TWI343259B (es) |
| UA (1) | UA83036C2 (es) |
| WO (1) | WO2004096191A1 (es) |
| ZA (1) | ZA200509549B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0506139D0 (en) * | 2005-03-24 | 2005-05-04 | Transphase Ltd | A transdermal topical composition and its uses |
| GB0506141D0 (en) * | 2005-03-24 | 2005-05-04 | Transphase Ltd | A topical compostion and its uses |
| DE102005015128B4 (de) * | 2005-03-31 | 2008-12-11 | Bayer Schering Pharma Aktiengesellschaft | Wafer enthaltend Steroidhormone |
| DE102005035879A1 (de) * | 2005-07-30 | 2007-02-01 | Paul Hartmann Ag | Hydrogel |
| SE536091C2 (sv) * | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter |
| CN103596550A (zh) * | 2011-04-25 | 2014-02-19 | 朴俊炯 | 用于预防脱发和促进毛发生长的局部施用的组合物 |
| FR2976808B1 (fr) * | 2011-06-22 | 2013-06-28 | Urgo Lab | Composition filmogene et son utilisation pour le traitement de l'herpes |
| US9855211B2 (en) * | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
| DE102018213754A1 (de) * | 2018-08-15 | 2020-02-20 | Henkel Ag & Co. Kgaa | "Tris(hydroxymethyl-)aminomethan oder seine Salze als Wirkstoff zur Reduzierung der Schweißsekretion“ |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3341557A (en) | 1961-06-05 | 1967-09-12 | Upjohn Co | 7-methyltestosterones |
| DE1182229B (de) | 1960-11-16 | 1964-11-26 | Upjohn Co | Verfahren zur Herstellung von 7-Methylsteroiden |
| US3924004A (en) | 1971-11-24 | 1975-12-02 | Syntex Corp | Fatty alcohol-propylene carbonate-glycol solvent cream vehicle |
| US4000273A (en) | 1973-11-01 | 1976-12-28 | Richardson-Merrell Inc. | Method for the control of fertility |
| JPS5540604A (en) * | 1978-09-14 | 1980-03-22 | Mitsui Toatsu Chem Inc | Improved local topicum |
| FR2518879A1 (fr) * | 1981-12-30 | 1983-07-01 | Besins Jean | Medicament a base d'oestradiol pour le traitement de la pathologie menopausique |
| JPS5970612A (ja) * | 1982-10-13 | 1984-04-21 | Nippon Redarii Kk | ゲル軟膏基剤 |
| WO1988009185A1 (en) * | 1987-05-27 | 1988-12-01 | Kurt Burghart | Transdermal therapeutically effective pharmaceutical dressing and device for applying it |
| EP0370220B1 (de) * | 1988-10-27 | 1996-01-10 | Schering Aktiengesellschaft | Mittel zur transdermalen Applikation enthaltend Gestoden |
| WO1993025168A1 (en) * | 1992-06-11 | 1993-12-23 | Theratech, Inc. | The use of glycerin in moderating transdermal drug delivery |
| US5460620A (en) * | 1992-07-31 | 1995-10-24 | Creative Products Resource, Inc. | Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent |
| WO1996008255A1 (en) | 1994-09-14 | 1996-03-21 | Minnesota Mining And Manufacturing Company | Transdermal device for delivery of levonorgestrel |
| FR2732223B1 (fr) | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
| DE19526864A1 (de) | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
| JPH09194396A (ja) | 1996-01-17 | 1997-07-29 | Pola Chem Ind Inc | 貼付剤用マトリックス |
| US5733565A (en) | 1996-02-23 | 1998-03-31 | The Population Council, Center For Biomedical Research | Male contraceptive implant |
| KR970064620A (ko) * | 1996-03-05 | 1997-10-13 | 임성기 | 사이클로스포린-함유 외용약제 조성물 |
| US5736128A (en) * | 1996-05-14 | 1998-04-07 | Isp Investments Inc. | Cosmetic composition for rejuvenation of skin without skin irritation |
| EP0954260A1 (en) | 1996-05-22 | 1999-11-10 | Diversified Pharmaceuticals, Inc. | Compositions, methods and devices for the transdermal delivery of drugs |
| IT1283102B1 (it) * | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
| US5993787A (en) | 1996-09-13 | 1999-11-30 | Johnson & Johnson Consumer Products, Inc. | Composition base for topical therapeutic and cosmetic preparations |
| US6767902B2 (en) | 1997-09-17 | 2004-07-27 | The Population Council, Inc. | Androgen as a male contraceptive and non-contraceptive androgen replacement |
| US20020012694A1 (en) | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
| DE69901250T2 (de) | 1998-06-19 | 2002-10-17 | Akzo Nobel Nv | 7.alpha.-methyl 19-nortestosteron undecanoat mit androgenischer aktivität |
| FR2781666B1 (fr) * | 1998-07-30 | 2000-09-08 | Oreal | Composition cosmetique solide et ses utilisations |
| JP2935113B1 (ja) * | 1998-09-24 | 1999-08-16 | 小林製薬株式会社 | インドメタシン経皮吸収剤 |
| JP2000264899A (ja) * | 1999-01-13 | 2000-09-26 | Taisho Pharmaceut Co Ltd | ステロイド外用剤 |
| WO2000041702A1 (fr) | 1999-01-13 | 2000-07-20 | Taisho Pharmaceutical Co., Ltd. | Preparation steroide externe |
| JP2001139451A (ja) * | 1999-11-17 | 2001-05-22 | Lion Corp | ジェル状化粧料 |
| CN1481388A (zh) | 2000-12-15 | 2004-03-10 | ��˹��ŵ�� | 具有雄激素-孕激素混合活性的14(15)-不饱和的15-和/或16-取代的雄激素类 |
| DE10104327A1 (de) * | 2001-01-24 | 2002-07-25 | Schering Ag | 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate |
| DE10107663B4 (de) | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
-
2004
- 2004-03-25 JO JO200439A patent/JO2492B1/en active
- 2004-04-19 TW TW093110876A patent/TWI343259B/zh not_active IP Right Cessation
- 2004-04-21 NZ NZ543264A patent/NZ543264A/en not_active IP Right Cessation
- 2004-04-21 ES ES04728563T patent/ES2300763T3/es not_active Expired - Lifetime
- 2004-04-21 KR KR1020057020394A patent/KR101093999B1/ko not_active IP Right Cessation
- 2004-04-21 WO PCT/EP2004/004224 patent/WO2004096191A1/de active IP Right Grant
- 2004-04-21 CA CA002523734A patent/CA2523734C/en not_active Expired - Fee Related
- 2004-04-21 AT AT04728563T patent/ATE385786T1/de active
- 2004-04-21 UA UAA200511102A patent/UA83036C2/ru unknown
- 2004-04-21 NZ NZ583760A patent/NZ583760A/en unknown
- 2004-04-21 MX MXPA05011541A patent/MXPA05011541A/es active IP Right Grant
- 2004-04-21 DE DE502004006196T patent/DE502004006196D1/de not_active Expired - Lifetime
- 2004-04-21 DK DK04728563T patent/DK1617827T3/da active
- 2004-04-21 EP EP07075742A patent/EP1875905B1/de not_active Expired - Lifetime
- 2004-04-21 RS YUP-2005/0809A patent/RS51307B/sr unknown
- 2004-04-21 SI SI200430685T patent/SI1617827T1/sl unknown
- 2004-04-21 EP EP04728563A patent/EP1617827B1/de not_active Expired - Lifetime
- 2004-04-21 BR BRPI0409918-4A patent/BRPI0409918A/pt not_active IP Right Cessation
- 2004-04-21 CN CN2004800114045A patent/CN1780610B/zh not_active Expired - Fee Related
- 2004-04-21 JP JP2006505217A patent/JP4829102B2/ja not_active Expired - Fee Related
- 2004-04-21 AT AT07075742T patent/ATE467412T1/de active
- 2004-04-21 PL PL04728563T patent/PL1617827T3/pl unknown
- 2004-04-21 ES ES07075742T patent/ES2345458T3/es not_active Expired - Lifetime
- 2004-04-21 DE DE502004011164T patent/DE502004011164D1/de not_active Expired - Lifetime
- 2004-04-21 AU AU2004233572A patent/AU2004233572B2/en not_active Ceased
- 2004-04-21 EA EA200501583A patent/EA008686B1/ru not_active IP Right Cessation
- 2004-04-21 PT PT04728563T patent/PT1617827E/pt unknown
- 2004-04-26 PE PE2004000409A patent/PE20050461A1/es not_active Application Discontinuation
- 2004-04-27 CL CL200400884A patent/CL2004000884A1/es unknown
- 2004-04-28 AR ARP040101436A patent/AR044113A1/es unknown
-
2005
- 2005-10-24 CR CR8059A patent/CR8059A/es unknown
- 2005-11-24 ZA ZA200509549A patent/ZA200509549B/en unknown
- 2005-11-25 CO CO05119657A patent/CO5640075A2/es not_active Application Discontinuation
- 2005-11-25 EC EC2005006186A patent/ECSP056186A/es unknown
- 2005-11-25 NO NO20055601A patent/NO20055601L/no not_active Application Discontinuation
-
2006
- 2006-07-14 HK HK06107921.3A patent/HK1087633A1/xx not_active IP Right Cessation
-
2008
- 2008-04-18 HR HR20080178T patent/HRP20080178T3/xx unknown
- 2008-05-13 CY CY20081100503T patent/CY1108069T1/el unknown
-
2010
- 2010-07-02 JP JP2010152291A patent/JP2010241824A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP056186A (es) | Composición farmacéutica en forma de hidrogel para administración transdérmica de sustancias activas | |
| CL2009001556A1 (es) | Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol. | |
| CL2009000541A1 (es) | Uso de una enzima degradadora de matriz activable (amde) para la formulacion de un medicamento de administracion sub-epidermica; composicion farmacologica y su uso; combinacion que comprende a amde, un activador y un agente; recipiente para amde y para el activador; kit que comprende dicho recipiente | |
| ES2649340T3 (es) | Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer | |
| AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
| CY1108700T1 (el) | Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης | |
| AR051765A1 (es) | Compuestos de moleculas conjugadas con una actividad reforzada de absorcion de celulas | |
| CL2009000035A1 (es) | Compuestos derivados 3-espiro-heterociclo-1il-5h-ciclopentan[d]pirimidin-indol, util para inhibir la actividad de akt quinasa; composicion farmaceutica que comprende dichos compuestos; y uso en el tratamiento de enfermedades tal como cancer, fibrosis quistica, diabetes, enfermedad de alzheimer, entre otras. | |
| CL2011000935A1 (es) | Composicion farmaceutica que comprende acetaminofeno y un material de tramadol complejo, que exhibe una liberacion sostenida y coordinada a traves de una capa de liberacion sostenida y otra de liberacion inmediata; metodo de preparacion;y el uso de un material complejo de tramadol y acetaminofeno para preparar un medicamento para el tratamiento del dolor. | |
| CR7999A (es) | Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero | |
| BRPI0516830A (pt) | composições de droga de liberação sustentada convenientemente implantáveis | |
| CL2007001435A1 (es) | Compuestos derivados de fenilalanina; proceso de prepatacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como inhibidores de integrina para el tratamiento del cancer. | |
| BRPI0915300C1 (pt) | compostos de éster boronato e composições farmacêuticas dos mesmos | |
| AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
| BRPI0517640A (pt) | composições farmacêuticas tópicas contendo um composto antiacne e um composto antibiótico | |
| AR055552A1 (es) | Preparacion topica refrescante para parches y metodos para utilizar la misma | |
| DE602005012289D1 (de) | Abgabevehikel mit nanoteilchen | |
| BR112012017168A2 (pt) | sistema terapêutico transdérmico para administração de rivastigmina ou seus derivados | |
| CA2784827C (en) | Composition of dexibuprofen transdermal hydrogel | |
| CL2008002307A1 (es) | Uso de un agente farmaceutico activable por un proceso de absorcion de dos fotones simultaneo, que efectua un cambio celular predeterminado cuando se activa y es util para tratar un trastorno de proliferacion celular. | |
| EA201001244A1 (ru) | Система доставки лекарственного средства со стабилизирующим эффектом | |
| AR078283A1 (es) | Formulaciones de suspension oral de dibenzazepina carboxamidas | |
| ATE549016T1 (de) | Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe | |
| AR048672A1 (es) | Tabletas de desintegracion que comprenden licarbazepina | |
| AR065068A1 (es) | Composicion farmaceutica que comprende tramadol y ketoprofeno en asociacion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |